| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ee537cb4716cde4a6651f1fadf04ffe6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_674697ebf921076e1cabd8592f41f6be
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d93cb25bec525d0e942c6d501b85d61e
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_a1a03b9d150d5d79db83008c241cd49a |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-50
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-495
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- |
| filingDate |
2007-11-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e23002906ae673ee1a573c8a8d1458bb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5d226cf6f78c1320f220697cf36f647c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58f7a47d45aa47e3bdf983dc2a1c9d17
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c617c93b21b0d4a941efe21fb9a7cc13 |
| publicationDate |
2008-05-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
US-2008125443-A1 |
| titleOfInvention |
Cardioprotective delta opioid receptor agonists and methods of using same |
| abstract |
The present invention relates to compositions and methods of treatment for cardioprotection through the use of non-peptidic delta opioid receptor agonist compound(s) that mediate cardioprotective effects of ischemic preconditioning. The compounds are used to reduce injury associated with ischemia and reperfusion of cardiac tissue. Further, the compounds may be used in solutions preserving the viability of an isolated organ. |
| priorityDate |
2003-01-02-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |